Lawrence Garrod毕生致力于抗生素的作用方式研究,并率先考察了抗生素的抗菌作用,细菌对患者损伤的类型及免疫应答等各方面的情况。后来他又适时地将其注意力集中到肺结核的治疗研究上,此时正值20世纪50年代早期链霉素问世。作者试图通过对肺结核化疗各个方面的总结来填补这一空白,其中有些问题是当今仍在争论的,而另一些则已获得了明确的结果。肺结核化疗发展的第一阶段开始于20世 Lawrence Garrod devoted his life to the study of the way antibiotics work, taking the lead in examining the antibacterial effects of antibiotics, the types of bacterial damage to patients, and the immune response. He later focused his attention on the treatment of tuberculosis in a timely manner, at a time when streptomycin came out early in the 1950s. The authors attempt to fill this gap by summarizing various aspects of tuberculosis chemotherapy, some of which are still debatable today, while others have had clear-cut results. The first phase of the development of tuberculosis chemotherapy began in twentieth Century